Lawmakers say the proposed Medicare policy could make it harder for patients to access newer cancer treatments by discouraging medical innovation.
<iframe src="https://statesidedaily.com/embed/cluster/d754906cb0ae75539761711fb698567a375f6abe" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Trump CMS faces bipartisan pushback over Medicare proposal tied to Biden-era drug pricing law"></iframe>
Lawmakers say the proposed Medicare policy could make it harder for patients to access newer cancer treatments by discouraging medical innovation.
